INAR Approach to Validation of Surrogate Endpoints

Our Findings Help Inform You on Next Step Decision-Making and Planning for Your Drug or Medical Device Our Approach Information from the validation of surrogate endpoints is used for decision-making at the company level or by HTA agencies for reimbursement. Our approach for validation of surrogate

more